|
Volumn 313, Issue 8, 2015, Pages 847-848
|
Hydroxychloroquine and the retina
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHLOROQUINE;
HYDROXYCHLOROQUINE;
HYDROXYCHLOROQUINE SULFATE;
ANTIRHEUMATIC AGENT;
ARTICLE;
DRUG USE;
EYE CARE;
HIGH RISK PATIENT;
HUMAN;
LONG TERM CARE;
MAJOR CLINICAL STUDY;
PERIMETRY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RETINA MACULOPATHY;
RHEUMATOID ARTHRITIS;
RHEUMATOLOGY;
RISK ASSESSMENT;
RISK FACTOR;
SCREENING TEST;
SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY;
SYSTEMIC LUPUS ERYTHEMATOSUS;
TREATMENT DURATION;
AMBULATORY CARE;
CHEMICALLY INDUCED;
FEMALE;
MALE;
RETINAL DISEASES;
UTILIZATION;
VISUAL SYSTEM EXAMINATION;
AMBULATORY CARE;
ANTIRHEUMATIC AGENTS;
CHLOROQUINE;
DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL;
FEMALE;
HUMANS;
HYDROXYCHLOROQUINE;
MALE;
RETINAL DISEASES;
|
EID: 84923294582
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.14558 Document Type: Article |
Times cited : (13)
|
References (7)
|